Catalyst Capital Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-12,000
Closed -$889K 271
2019
Q4
$889K Sell
12,000
-7,900
-40% -$493K 0.03% 128
2019
Q3
$1.14M Buy
+19,900
New +$1.32M 0.04% 123
2019
Q2
Sell
-583
Closed -$43K 445
2019
Q1
$43K Sell
583
-1,100
-65% -$77.3K ﹤0.01% 241
2018
Q4
$100K Sell
1,683
-924
-35% -$74.5K ﹤0.01% 259
2018
Q3
$246K Sell
2,607
-5,310
-67% -$457K 0.01% 230
2018
Q2
$594K Sell
7,917
-1,377
-15% -$98.9K 0.02% 206
2018
Q1
$563K Buy
9,294
+6,094
+190% +$330K 0.02% 188
2017
Q4
$149K Buy
+3,200
New +$158K 0.01% 262

Other funds holding HQY

Catalyst Capital Advisors's HQY Position: Q1 2020 in Review

Catalyst Capital Advisors sold out of HealthEquity (HQY) in Q1 2020, closing a stake of 12,000 shares — an estimated $889K sold.

Catalyst Capital Advisors first reported a position in HQY in Q4 2017 and held it in 8 quarters. The position peaked at $1.14M in Q3 2019. 288 funds tracked by Wall St. Rank hold HQY as of Q1 2020.

  • Catalyst Capital Advisors reported no remaining HealthEquity position as of Q1 2020 after selling out during the quarter.
  • Catalyst Capital Advisors sold 12,000 HealthEquity shares in Q1 2020, an estimated $889K.
  • Catalyst Capital Advisors first reported a position in HealthEquity in Q4 2017 and held it in 8 quarters.
  • Catalyst Capital Advisors's HealthEquity position peaked at $1.14M in Q3 2019.
  • 288 funds tracked by Wall St. Rank held HealthEquity as of Q1 2020.

Based on Catalyst Capital Advisors's 13F filing for Q1 2020, filed 12 May 2020.